Effects of inflammation and treatment on bone turnover and bone mass in polymyalgia rheumatica.

Author: CorrigallV, DasguptaB, DolanA L, LiF, MackintoshC, MonizC, PanayiG S, ToddP

Paper Details 
Original Abstract of the Article :
Polymyalgia rheumatica (PMR) has an abrupt onset of inflammatory symptoms, making it a useful model for studying the effects of inflammation in bone. PMR requires corticosteroid treatment, which may itself have a detrimental effect on bone. This study used serially measured biochemical markers of bo...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/art.1780401115

データ提供:米国国立医学図書館(NLM)

The Impact of Inflammation on Bone in Polymyalgia Rheumatica

Polymyalgia rheumatica (PMR), a condition characterized by widespread muscle pain and stiffness, can be like a desert sandstorm—a sudden and intense onslaught of discomfort. This research investigates the effects of inflammation and corticosteroid treatment on bone metabolism in patients with PMR. The study examines the interplay between inflammation and corticosteroid therapy, two key factors that can influence bone health.

Inflammation and Corticosteroids: A Double-Edged Sword for Bone

The study reveals the complex relationship between inflammation, corticosteroid treatment, and bone loss in PMR. The researchers found that both inflammation and corticosteroid therapy can contribute to bone loss in patients with PMR. This finding underscores the importance of carefully managing both inflammation and corticosteroid use to minimize the risk of bone complications.

Protecting Bone Health in Polymyalgia Rheumatica

This research, a beacon in the vast desert of bone health research, emphasizes the importance of a multi-faceted approach to managing PMR. Patients with PMR require careful monitoring and treatment to minimize the risk of bone complications associated with both inflammation and corticosteroid therapy. Early intervention and appropriate management strategies are crucial for preserving bone health in these individuals.

Dr.Camel's Conclusion

This research, like a desert oasis, offers valuable insights into the complex relationship between inflammation, corticosteroid therapy, and bone health in patients with PMR. The study highlights the importance of managing both inflammation and corticosteroid use to protect bone health in these individuals. It's a reminder that even in the face of challenging medical conditions, there are opportunities to improve patient outcomes through careful management and personalized care.

Date :
  1. Date Completed 1997-12-02
  2. Date Revised 2019-07-18
Further Info :

Pubmed ID

9365092

DOI: Digital Object Identifier

10.1002/art.1780401115

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.